Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Cost of Revenue (2016 - 2025)

Bio-Techne (TECH) has 17 years of Cost of Revenue data on record, last reported at $104.6 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 1.41% year-over-year to $104.6 million; the TTM value through Dec 2025 reached $422.8 million, up 2.83%, while the annual FY2025 figure was $429.4 million, 10.28% up from the prior year.
  • Cost of Revenue reached $104.6 million in Q4 2025 per TECH's latest filing, up from $98.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $118.2 million in Q2 2025 and bottomed at $75.3 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $94.8 million, with a median of $94.0 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: soared 32.89% in 2021, then decreased 7.51% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $85.6 million in 2021, then rose by 3.08% to $88.2 million in 2022, then rose by 8.83% to $96.0 million in 2023, then grew by 7.43% to $103.1 million in 2024, then rose by 1.41% to $104.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $104.6 million in Q4 2025, $98.4 million in Q3 2025, and $118.2 million in Q2 2025.